Barclays
SRZN icon

Barclays’s Surrozen SRZN Stock Holding History

Barclays’s Portfolio SRZN Stock Details SRZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55K Buy
+1,888
New +$45.3K ﹤0.01% 4283
2025
Q4 		– Sell
-13
Closed -$168 – 5662
2025
Q3 		$168 Buy
+13
New +$136 ﹤0.01% 5249
2024
Q4 		– Sell
-25
Closed -$300 – 5466
2024
Q3 		$300 Buy
+25
New +$221 ﹤0.01% 5161

Other funds holding SRZN

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM

Barclays's SRZN Position: Q1 2026 in Review

Barclays opened a new position in Surrozen (SRZN) in Q1 2026: 1,888 shares worth $55K. The stake represents ﹤0.01% of the portfolio and ranks #4283 among its holdings. This is a return to the name: Barclays previously reported a position in SRZN as recently as Q3 2025.

Barclays first reported a position in SRZN in Q3 2024 and has held it in 3 quarters since. 59 funds tracked by Wall St. Rank hold SRZN as of Q1 2026.

  • Barclays held 1,888 shares of Surrozen worth $55K as of Q1 2026.
  • Surrozen was a new Barclays position in Q1 2026.
  • Surrozen made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4283 holding.
  • Barclays first reported a position in Surrozen in Q3 2024 and has held it in 3 quarters since.
  • 59 funds tracked by Wall St. Rank held Surrozen as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.